Clinical Trials Logo
  1. Home
  2. Spinal Muscular Atrophy Type II
  3. NCT05416034

Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy

Spinal Muscular Atrophy Type II Clinical Trial

Official title:
Study of the Impact of a Gait Exoskeleton on the Quality of Life of Patients With Spinal Muscular Atrophy

Clinical Trial Summary

The purpose of this study is to evaluate the impact of the use of a pediatric exoskeleton on the quality of life of children, specifically in the psychological and care dimensions. Other objectives are to evaluate changes at the physical and functional level.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05416034
Study type Interventional
Source MarsiBionics
Contact
Status Completed
Phase N/A
Start date December 1, 2017
Completion date August 31, 2018
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05715749 - Body Weight Support Harness System in Spinal Muscular Atrophy N/A
Not yet recruiting NCT06300996 - Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb N/A
Completed NCT01302600 - Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients. Phase 2
Terminated NCT00439569 - Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III Phase 1/Phase 2
Active, not recruiting NCT04042025 - Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi Phase 3
Enrolling by invitation NCT06137612 - Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy
Recruiting NCT03709784 - Spinraza in Adult Spinal Muscular Atrophy
Active, not recruiting NCT05626855 - Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX Phase 3